| ENDOVX, INC. Napa, CA |
|
|||||||
| EndoVx, Inc. is developing a novel medical device system for non-invasively treating obesity. Our approach is based on a successful surgical study that showed effective long term weight loss. Our proprietary procedure is quick, bloodless, and done on an out-patient basis. EndoVx will demonstrate the performance of the system and generate additional clinical data with the Series A funding. TASCF co-led the Series A round with Asset Management of Palo Alto. | ||||||||
 |
||||||||
